Sumino H, Nakamura T, Kanda T, Sakamaki T, Sato K, Saito Y, Hoshino J, Kurashina T, Ono Z, Takahashi T, Ichikawa S, Kurabayashi M, Nagai R
Second Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.
Jpn Heart J. 2000 May;41(3):339-48. doi: 10.1536/jhj.41.339.
The mechanisms responsible for regression of left ventricular (LV) mass with antihypertensive therapy in patients with severe hypertension remain unclear. This study was designed to examine whether systolic and diastolic blood pressures are associated with changes in LV mass. Eighteen patients with essential hypertension whose average seated diastolic blood pressure was >or = 110 mm Hg were enrolled in the study. All patients were administered antihypertensive therapy and underwent M-mode echocardiography before and after 6 months of treatment. In all patients, antihypertensive treatment significantly reduced systolic blood pressure from 175 +/- 21 mm Hg at baseline to 143 +/- 22 mm Hg at 6 months (p < 0.001), and diastolic blood pressure from 116 +/- 7 mm Hg at baseline to 92 +/- 20 mm Hg at 6 months (p < 0.001). LV mass index at 6 months was significantly reduced compared to its baseline value (p < 0.05). Change (value at 6 months-value at baseline) in systolic and diastolic blood pressures correlated positively with the change in LV mass index (r = 0.61, p < 0.01 and r = 0.71, p < 0.001, respectively). The patients were divided into responders. whose LV mass regressed by > or = 10% (n = 9), and nonresponders, whose LV mass regressed by < 10% (n = 9). Systolic (p < 0.001) and diastolic (p < 0.001) blood pressures. interventricular septal thickness (p< 0.05), posterior wall thickness (p < 0.001), and LV mass index (p < 0.001) were significantly decreased in the responders, but not in the nonresponders, at 6 months compared with those at baseline. Systolic (p < 0.05) and diastolic (p < 0.05) blood pressures in nonresponders were significantly higher than those in the responders at 6 months. The changes in systolic and diastolic blood pressures did not correlate with the change in LV mass index in the responders or the nonresponders. The regression of LV mass is strongly affected by reducing blood pressure. This is the first study using antihypertensive therapy to demonstrate that a change in blood pressure correlates positively with changes in LV mass index in severely hypertensive patients.
重度高血压患者经抗高血压治疗后左心室(LV)质量消退的机制尚不清楚。本研究旨在检验收缩压和舒张压是否与LV质量变化相关。18例原发性高血压患者入组本研究,其平均坐位舒张压≥110 mmHg。所有患者均接受抗高血压治疗,并在治疗6个月前后接受M型超声心动图检查。所有患者中,抗高血压治疗使收缩压从基线时的175±21 mmHg显著降至6个月时的143±22 mmHg(p<0.001),舒张压从基线时的116±7 mmHg显著降至6个月时的92±20 mmHg(p<0.001)。6个月时的LV质量指数与基线值相比显著降低(p<0.05)。收缩压和舒张压的变化(6个月时的值-基线时的值)与LV质量指数的变化呈正相关(分别为r=0.61,p<0.01和r=0.71,p<0.001)。患者被分为反应者(LV质量消退≥10%,n=9)和无反应者(LV质量消退<10%,n=9)。与基线时相比,6个月时反应者的收缩压(p<0.001)、舒张压(p<0.001)、室间隔厚度(p<0.05)、后壁厚度(p<0.001)和LV质量指数(p<0.001)显著降低,而无反应者则无显著变化。6个月时,无反应者的收缩压(p<0.05)和舒张压(p<0.05)显著高于反应者。反应者和无反应者的收缩压和舒张压变化与LV质量指数变化均无相关性。降低血压对LV质量的消退有强烈影响。这是第一项使用抗高血压治疗来证明血压变化与重度高血压患者LV质量指数变化呈正相关的研究。